Metformin promotes cell proliferation and osteogenesis under high glucose condition by regulating the ROS‑AKT‑mTOR axis

Zhou,Renyi; Ma,Yue; Qiu,Shui; Gong,Zunlei; Zhou,Xiaoshu

doi:10.3892/mmr.2020.11391

Metformin promotes cell proliferation and osteogenesis under high glucose condition by regulating the ROS‑AKT‑mTOR axis

Authors:
- Renyi Zhou
- Yue Ma
- Shui Qiu
- Zunlei Gong
- Xiaoshu Zhou
View Affiliations

Affiliations: Department of Orthopedics, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China, Department of Respiratory and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: July 30, 2020 https://doi.org/10.3892/mmr.2020.11391
Pages: 3387-3395
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Metformin, a cost‑effective and safe orally administered antidiabetic drug used by millions of patients, has exhibited great interest for its potential osteogenic‑promoting properties in different types of cells, including mesenchymal stem cells (MSCs). Diabetic osteopathy is a common comorbidity of diabetes mellitus; however, the underlying molecular mechanisms of metformin on the physiological processes of MSCs, under high glucose condition, remain unknown. To determine the effects of metformin on the regulatory roles of proliferation and differentiation in MSCs, under high glucose conditions, osteogenesis after metformin treatment was detected with Alizarin Red S and ALP staining. The results demonstrated that high glucose levels significantly inhibited cell proliferation and osteogenic differentiation under high glucose conditions. Notably, addition of metformin reversed the inhibitory effects induced by high glucose levels on cell proliferation and osteogenesis. Furthermore, high glucose levels significantly decreased mitochondrial membrane potential (MMP), whereas treatment with metformin helped maintain MMP. Further analysis of mitochondrial function revealed that metformin significantly promoted ATP synthesis, mitochondrial DNA mass and mitochondrial transcriptional activity, which were inhibited by high glucose culture. Furthermore, metformin significantly scavenged reactive oxygen species (ROS) induced by high glucose levels, and regulated the ROS‑AKT‑mTOR axis inhibited by high glucose levels, suggesting the protective effects of metformin against high glucose levels via regulation of the ROS‑AKT‑mTOR axis. Taken together, the results of the present study demonstrated the protective role of metformin on the physiological processes of MSCs, under high glucose condition and highlighted the potential molecular mechanism underlying the effect of metformin in promoting cell proliferation and osteogenesis under high glucose condition.

View Figures

View References

1	Janghorbani M, Van Dam RM, Willett WC and Hu FB: Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 166:3387–505. 2007. View Article : Google Scholar
2	Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F and Galofré JC: The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis. J Clin Endocrinol Metab. 99:923–931. 2014. View Article : Google Scholar : PubMed/NCBI
3	Dhaliwal R, Cibula D, Ghosh C, Weinstock RS and Moses AM: Bone quality assessment in type 2 diabetes mellitus. Osteoporos Int. 25:1969–1973. 2014. View Article : Google Scholar : PubMed/NCBI
4	Chen Y, Hu Y, Yang L, Zhou J, Tang Y, Zheng L and Qin P: Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3β/β-catenin pathway. Cell Biol Int. 41:822–832. 2017. View Article : Google Scholar : PubMed/NCBI
5	Harvey NC, McCloskey EV, Mitchell PJ, Dawson-Hughes B, Pierroz DD, Reginster JY, Rizzoli R, Cooper C and Kanis JA: Mind the (treatment) gap: A global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int. 28:1507–1529. 2017. View Article : Google Scholar : PubMed/NCBI
6	Jackuliak P and Payer J: Osteoporosis, fractures, and diabetes. Int J Endocrinol. 2014:8206152014. View Article : Google Scholar : PubMed/NCBI
7	Wybier M, Mathieu P, Morvan G, Vuillemin Bodaghi V and Guerini H: Muculoskeletal radiology: ankle and foot in adults. J Radiol. 89:711–724, quis 735-736. 2008.(In French). View Article : Google Scholar : PubMed/NCBI
8	Rosenbloom AL and Silverstein JH: Connective tissue and joint disease in diabetes mellitus. Endocrinol Metab Clin North Am. 25:473–483. 1996. View Article : Google Scholar : PubMed/NCBI
9	Smith DG, Barnes BC, Sands AK, Boyko EJ and Ahroni JH: Prevalence of radiographic foot abnormalities in patients with diabetes. Foot Ankle Int. 18:342–346. 1997. View Article : Google Scholar : PubMed/NCBI
10	Markowicz Piasecka M, Sikora J, Szydlowska A, Skupien A, Mikiciuk Olasik E and Huttunen KM: Metformin - a future therapy for neurodegenerative diseases: Theme: Drug discovery, development and delivery in Alzheimer's disease guest editor: Davide Brambilla. Pharm Res. 34:2614–2627. 2017. View Article : Google Scholar : PubMed/NCBI
11	Cortizo AM, Sedlinsky C, McCarthy AD, Blanco A and Schurman L: Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. Eur J Pharmacol. 536:38–46. 2006. View Article : Google Scholar : PubMed/NCBI
12	Gao Y, Xue J, Li X, Jia Y and Hu J: Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells. J Pharm Pharmacol. 60:1695–1700. 2008. View Article : Google Scholar : PubMed/NCBI
13	Zhen D, Chen Y and Tang X: Metformin reverses the deleterious effects of high glucose on osteoblast function. J Diabetes Complications. 24:334–344. 2010. View Article : Google Scholar : PubMed/NCBI
14	Shao X, Cao X, Song G, Zhao Y and Shi B: Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation. J Diabetes Res. 2014:4539402014. View Article : Google Scholar : PubMed/NCBI
15	Renner K, Seilbeck A, Kauer N, Ugele I, Siska PJ, Brummer C, Bruss C, Decking SM, Fante M, Schmidt A, et al: Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells. Front Pharmacol. 9:12582018. View Article : Google Scholar : PubMed/NCBI
16	Wang X, Feng Z, Li J, Chen L and Tang W: High glucose induces autophagy of MC3T3-E1 cells via ROS-AKT-mTOR axis. Mol Cell Endocrinol. 429:62–72. 2016. View Article : Google Scholar : PubMed/NCBI
17	Park KR, Nam D, Yun HM, Lee SG, Jang HJ, Sethi G, Cho SK and Ahn KS: β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Lett. 312:178–188. 2011. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Fiorini C, Cordani M, Gotte G, Picone D and Donadelli M: Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner. Biochim Biophys Acta. 1853:549–560. 2015. View Article : Google Scholar : PubMed/NCBI
20	Botushanov NP and Orbetzova MM: Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus. Folia Med (Plovdiv). 51:12–17. 2009.PubMed/NCBI
21	Wang C, Li H, Chen SG, He JW, Sheng CJ, Cheng XY, Qu S, Wang KS, Lu ML and Yu YC: The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice. J Bone Miner Metab. 30:630–637. 2012. View Article : Google Scholar : PubMed/NCBI
22	Sun H, Dai K, Tang T and Zhang X: Regulation of osteoblast differentiation by slit2 in osteoblastic cells. Cells Tissues Organs. 190:69–80. 2009. View Article : Google Scholar : PubMed/NCBI
23	Granero-Moltó F, Weis JA, Miga MI, Landis B, Myers TJ, O'Rear L, Longobardi L, Jansen ED, Mortlock DP and Spagnoli A: Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells. 27:1887–1898. 2009. View Article : Google Scholar : PubMed/NCBI
24	Li C, Yang L, Ren X, Lin M, Jiang X, Shen D, Xu T, Ren J, Huang L, Qing W, et al: Groove structure of porous hydroxyapatite scaffolds (HAS) modulates immune environment via regulating macrophages and subsequently enhances osteogenesis. J Biol Inorg Chem. 24:733–745. 2019. View Article : Google Scholar : PubMed/NCBI
25	Yang J, Ma C and Zhang M: High glucose inhibits osteogenic differentiation and proliferation of MC3T3 E1 cells by regulating P2X7. Mol Med Rep. 20:5084–5090. 2019.PubMed/NCBI
26	Sharma U, Pal D and Prasad R: Alkaline phosphatase: An overview. Indian J Clin Biochem. 29:269–278. 2014. View Article : Google Scholar : PubMed/NCBI
27	Takanche JS, Kim JE, Han SH and Yi HK: Effect of gomisin A on osteoblast differentiation in high glucose-mediated oxidative stress. Phytomedicine. 66:1531072020. View Article : Google Scholar : PubMed/NCBI
28	Liu J, Shen W, Zhao B, Wang Y, Wertz K, Weber P and Zhang P: Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients. Adv Drug Deliv Rev. 61:1343–1352. 2009. View Article : Google Scholar : PubMed/NCBI